ATE263169T1 - Triazolopyridine für behandlung von thrombosen - Google Patents

Triazolopyridine für behandlung von thrombosen

Info

Publication number
ATE263169T1
ATE263169T1 AT99937373T AT99937373T ATE263169T1 AT E263169 T1 ATE263169 T1 AT E263169T1 AT 99937373 T AT99937373 T AT 99937373T AT 99937373 T AT99937373 T AT 99937373T AT E263169 T1 ATE263169 T1 AT E263169T1
Authority
AT
Austria
Prior art keywords
triazolopyridines
thrombosis
treatment
Prior art date
Application number
AT99937373T
Other languages
English (en)
Inventor
William J Hoekstra
Edward C Lawson
Bruce E Maryanoff
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE263169T1 publication Critical patent/ATE263169T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99937373T 1998-07-27 1999-07-21 Triazolopyridine für behandlung von thrombosen ATE263169T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9423198P 1998-07-27 1998-07-27
US09/354,032 US6303625B1 (en) 1998-07-27 1999-07-15 Triazolopyridines for the treatment of thrombosis disorders
PCT/US1999/016572 WO2000006570A1 (en) 1998-07-27 1999-07-21 Triazolopyridines for the treatment of thrombosis disorders

Publications (1)

Publication Number Publication Date
ATE263169T1 true ATE263169T1 (de) 2004-04-15

Family

ID=22243910

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99937373T ATE263169T1 (de) 1998-07-27 1999-07-21 Triazolopyridine für behandlung von thrombosen

Country Status (21)

Country Link
US (1) US6303625B1 (de)
EP (1) EP1102766B1 (de)
JP (1) JP2003527306A (de)
KR (1) KR20010079576A (de)
CN (1) CN1320125A (de)
AR (1) AR019477A1 (de)
AT (1) ATE263169T1 (de)
AU (1) AU757512B2 (de)
BR (1) BR9912556A (de)
CA (1) CA2338654A1 (de)
CZ (1) CZ2001347A3 (de)
DE (1) DE69916073T2 (de)
ES (1) ES2219042T3 (de)
HU (1) HUP0103832A3 (de)
ID (1) ID27214A (de)
MX (1) MXPA01001099A (de)
NO (1) NO20010456L (de)
PL (1) PL345769A1 (de)
SK (1) SK1342001A3 (de)
WO (1) WO2000006570A1 (de)
ZA (1) ZA200100783B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306909B1 (en) 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents
ES2270868T3 (es) * 1999-08-13 2007-04-16 Biogen Idec Ma Inc. Inhibidores de la adhesion celular.
TWI288745B (en) 2000-04-05 2007-10-21 Daiichi Seiyaku Co Ethylenediamine derivatives
CA2448160A1 (en) * 2001-05-25 2002-12-05 Queen's University At Kingston Heterocyclic beta-amino acids and their use as anti-epileptogenic agents
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
JP2008509985A (ja) * 2004-08-18 2008-04-03 ファルマシア アンド アップジョン カンパニー リミテッド ライアビリティ カンパニー 炎症治療用の新規トリアゾロピリジン化合物
WO2006052962A2 (en) * 2004-11-10 2006-05-18 Janssen Pharmaceutica, N.V. Bicyclic triazole a4 integrin inhibitors
BRPI0615775B1 (pt) * 2005-09-16 2021-08-10 Daiichi Sankyo Company, Limited Processos para a produção de compostos derivados de diamida oticamente ativos
EP2086973B1 (de) * 2006-10-11 2012-01-25 Amgen Inc., Imidazo- und triazolopyridinverbindungen und verfahren zu deren anwendung
EP2417135A1 (de) * 2009-04-07 2012-02-15 Schering Corporation Substituierte triazolopyridine und analoga davon
US8871760B2 (en) * 2009-09-21 2014-10-28 Roche Palo Alto Llc [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
UY34329A (es) 2011-09-15 2013-04-30 Novartis Ag Compuestos de triazolopiridina
EP3004095A1 (de) * 2013-06-03 2016-04-13 Bayer Pharma Aktiengesellschaft Triazolopyridine als thrombininhibitoren zur behandlung von thromboembolischen erkrankungen
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
CN119997982A (zh) 2022-09-09 2025-05-13 迈里克斯制药有限公司 包含nmt抑制剂的抗体药物偶联物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050525A (en) 1960-12-14 1962-08-21 John B Bicking Certain derivatives of s-triazolo [4, 3-a]-pyridine
SK102495A3 (en) 1993-02-22 1997-01-08 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical agents containing them
DE4326758A1 (de) * 1993-08-10 1995-02-16 Basf Ag [1,3,4]Triazolo[1,5-a]pyridine
CA2134192A1 (en) 1993-11-12 1995-05-13 Michael L. Denney 5, 6-bicyclic glycoprotein iib/iiia antagonists

Also Published As

Publication number Publication date
NO20010456D0 (no) 2001-01-26
JP2003527306A (ja) 2003-09-16
EP1102766A1 (de) 2001-05-30
ID27214A (id) 2001-03-08
EP1102766B1 (de) 2004-03-31
KR20010079576A (ko) 2001-08-22
MXPA01001099A (es) 2002-04-24
US6303625B1 (en) 2001-10-16
AR019477A1 (es) 2002-02-20
CZ2001347A3 (cs) 2001-12-12
DE69916073D1 (de) 2004-05-06
WO2000006570A1 (en) 2000-02-10
HUP0103832A2 (hu) 2002-04-29
ZA200100783B (en) 2002-01-28
SK1342001A3 (en) 2002-04-04
CA2338654A1 (en) 2000-02-10
DE69916073T2 (de) 2004-12-30
AU5221899A (en) 2000-02-21
PL345769A1 (en) 2002-01-02
ES2219042T3 (es) 2004-11-16
HUP0103832A3 (en) 2002-12-28
CN1320125A (zh) 2001-10-31
BR9912556A (pt) 2002-01-15
AU757512B2 (en) 2003-02-20
NO20010456L (no) 2001-03-26

Similar Documents

Publication Publication Date Title
DE69927823D1 (de) Hydrogel für die therapeutische behandlung von aneurysmas
EP1017402A4 (de) Behandlung des übersäuerten darmsyndroms
DE60138129D1 (de) Apparat zur behandlung von zähnen
DE69806579D1 (de) Anlage zur behandlung von nahrungsmitteln
DE59500555D1 (de) Mittel zur Wasserbehandlung
ATE295519T1 (de) Behandlung von kohlenwasserstoffgas
DE60001421D1 (de) Behandlung von abgas
DE69500089D1 (de) Behandlung von Geflügel
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE69812603D1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
ATE300597T1 (de) Behandlung von geweben
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
ATE263777T1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
DE69916073D1 (de) Triazolopyridine für behandlung von thrombosen
DE60014928D1 (de) Retinoide zur behandlung von emphysem
DE69501172D1 (de) Einrichtung für die Behandlung von Substrat
EP1117431A4 (de) Behandlung von acidose
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
DE69900339D1 (de) Mittel und Verfahren zur Behandlung von Kunstfasern
DE69033413D1 (de) Mittel zur Behandlung von Metalloberflächen
DE59801385D1 (de) Durchlaufanlage für die behandlung von werkstücken
DE69926485D1 (de) Behandlung von durchblasgasen
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties